• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

UC San Francisco - Articles and news items

Immunotherapy plus live bacterium shows promise in malignant pleural mesothelioma

Industry news / 14 April 2016 / Victoria White, Digital Content Producer

Immunotherapy with a live bacterium combined with chemotherapy demonstrated more than 90% disease control and 59% response rate in malignant pleural mesothelioma…


Webinar: NIR Spectroscopy for Assessing Blend Uniformity in the Pharmaceutical IndustryLEARN MORE
+ +